Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
AssigneeMannKind Corporation
InventorsBryan R. Wilson, Marshall Grant
Life of this patent
Estimating the term…
Abstract
Methods are provided for drying a particle. Specifically, there is provided a spray-dried diketopiperazine-insulin particle formulation having improved aerodynamic performance and in which the active agent is more stabile and efficiently delivered as compared to that of the lyophilized diketopiperazine-insulin formulation. The dry powders have utility as pharmaceutical formulations for pulmonary delivery.
Claims9
A process for manufacturing a crystalline microparticle of a diketopiperazine loaded with an active agent wherein the diketopiperazine has the formula of 2,5-diketo-3,6-di(4-X-aminobutyl)piperazine, wherein X is a succinyl, glutaryl, maleyl, or fumaryl group comprising the steps of:
- adding the diketopiperazine in a to water to form an aqueous suspension, maintaining the diketopiperazone solution at a controlled temperature between about 15° C. to about 18° C., adding the active agent to water to form an aqueous solution or suspension of the active, mixing the diketopiperazine aqueous suspension with the active agent aqueous solution or suspension, and then spray-drying the admixture to remove solvent, using a spray dryer having an inlet and outlet, to form a spray-dried powder.
Dependencies are inferred from the claim text.